Peginterferon alfa-2a
Successful treatment of hairy cell leukaemia with pegylated interferon-alpha-2A
A global comparison of hepatitis B & C drug pricing
HBV-specific T-cell function is nonenhanced by tenofovir-induced decline in HBV viremia or HBsAg titer in chronic hepatitis B
A greater frequency of circulating CCR7loPD-1hi follicular helper T cells indicates a durable clinical cure after Peg IFN-α therapy in chronic hepatitis B patients
Cytologic Diagnosis of Lymphomatoid Granulomatosis, A Case Report and Review of the Literature
Navigating the peginterferon Alfa-2a shortage: practical guidance on transitioning patients to ropeginterferon alfa-2b
Frequency, Severity and Impact of Pegylated Interferon Alpha-Associated Flares in Hepatitis D Infection
A case of chronic hepatitis B who achieved clinical cure with pegylated interferon alfa intermittent and combination therapy
see
Peginterferon alfa-2a for cystic craniopharyngioma treatment
.